Platelet Aggregation Inhibitors
"Platelet Aggregation Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
| Descriptor ID |
D010975
|
| MeSH Number(s) |
D27.505.954.502.780
|
| Concept/Terms |
Platelet Aggregation Inhibitors- Platelet Aggregation Inhibitors
- Aggregation Inhibitors, Platelet
- Inhibitors, Platelet Aggregation
- Blood Platelet Antiaggregants
- Antiaggregants, Blood Platelet
- Platelet Antiaggregants
- Antiaggregants, Platelet
- Blood Platelet Aggregation Inhibitors
Antiplatelet Agents- Antiplatelet Agents
- Agents, Antiplatelet
- Antiplatelet Drugs
- Drugs, Antiplatelet
Platelet Antagonists- Platelet Antagonists
- Antagonists, Platelet
- Blood Platelet Antagonists
- Antagonists, Blood Platelet
|
Below are MeSH descriptors whose meaning is more general than "Platelet Aggregation Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Platelet Aggregation Inhibitors".
This graph shows the total number of publications written about "Platelet Aggregation Inhibitors" by people in this website by year, and whether "Platelet Aggregation Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 2 | 4 |
| 1999 | 0 | 5 | 5 |
| 2000 | 4 | 2 | 6 |
| 2001 | 3 | 1 | 4 |
| 2002 | 7 | 4 | 11 |
| 2003 | 7 | 2 | 9 |
| 2004 | 17 | 8 | 25 |
| 2005 | 13 | 4 | 17 |
| 2006 | 12 | 4 | 16 |
| 2007 | 5 | 4 | 9 |
| 2008 | 14 | 5 | 19 |
| 2009 | 12 | 8 | 20 |
| 2010 | 7 | 5 | 12 |
| 2011 | 5 | 4 | 9 |
| 2012 | 3 | 4 | 7 |
| 2013 | 7 | 5 | 12 |
| 2014 | 8 | 1 | 9 |
| 2015 | 5 | 1 | 6 |
| 2016 | 8 | 6 | 14 |
| 2017 | 12 | 9 | 21 |
| 2018 | 17 | 5 | 22 |
| 2019 | 12 | 8 | 20 |
| 2020 | 7 | 6 | 13 |
| 2021 | 7 | 9 | 16 |
| 2022 | 2 | 7 | 9 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platelet Aggregation Inhibitors" by people in Profiles.
-
Optimizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Older Adults. JAMA Netw Open. 2024 Mar 04; 7(3):e246951.
-
Aspirin delays the metabolic clock of gestation in women at risk of preeclampsia: abridged secondary publication. Hong Kong Med J. 2024 Feb; 30 Suppl 1(1):45-46.
-
Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease. Am J Med. 2024 Mar; 137(3):202-209.
-
Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation. Circulation. 2024 03 05; 149(10):734-743.
-
Endoluminal flow diversion as a primary treatment strategy for pediatric traumatic intracranial aneurysms: a case-based review of literature. Childs Nerv Syst. 2024 Feb; 40(2):345-357.
-
Safety of routine protamine in the reversal of heparin in percutaneous coronary intervention: A systematic review and meta-analysis. Int J Cardiol. 2023 10 01; 388:131168.
-
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient. Anesthesiology. 2023 05 01; 138(5):535-560.
-
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits. J Vasc Surg. 2023 04; 77(4):1107-1118.e2.
-
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 Oct 11; 146(15):e205-e223.
-
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review. Ann Pharmacother. 2023 05; 57(5):544-552.